Evaluation of the Effect of Smoking on Pyroptosis in Periodontal Pathogenesis
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Gedetailleerde beschrijving
The aim of this research is to clarify the molecular link between tobacco use and pyroptotic cell death pathways in the pathogenesis of periodontal disease. To eliminate systemic bias, only systemically healthy participants are included. The study design consists of 6 distinct groups based on a 2x3 matrix (Smoking Status: Yes/No × Periodontal Status: Healthy/Gingivitis/Periodontitis).
Protein levels of the NLRP3 inflammasome and pro-inflammatory cytokines (IL-1beta, IL-18) are measured in periodontal tissues using the ELISA method. Furthermore, the mRNA expressions of Toll-like receptors (TLR1, TLR4, and TLR6) are analyzed via RT-PCR. These findings will help determine how smoking influences tissue destruction mechanisms specifically through the pyroptosis pathway in different stages of gum disease.
Studietype
Studietype
Inschrijving (Werkelijk)
Inschrijving
Contacten en locaties
Studie Locaties
-
-
Isparta
-
Isparta, Isparta, Turkije (Türkiye), 32000
- Suleyman Demirel University, Faculty of Dentistry, Department of Periodontology
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Individuals who voluntarily agreed to participate in the study,
- Smokers (gingivitis and stage 3/4 generalized periodontitis) and non-smokers (gingivitis and stage 3/4 generalized periodontitis) who applied to the Periodontology Clinical of Suleyman Demirel University Faculty of Dentistry,
- Individuals without any systemic diseases and without using any medications that affect periodontal health were included.
Exclusion Criteria:
- Individuals who refuse to participate in the study or who cannot comply with the study protocol,
- Individuals participating in another clinical trial concurrently, Individuals who have received periodontal treatment within the last 6 months,
- Individuals who have used medications (antibiotics, anti-inflammatory drugs, etc.) that may affect periodontal parameters within the last 3 months,
- Individuals with systemic diseases that may affect the periodontium,
- Individuals with systemic diseases presenting with oral symptoms,
- Individuals with malignant disease,
- Pregnant or lactating women,
- Individuals with psychological or physical disabilities,
- Individuals with substance abuse,
- Individuals with severe malocclusion, undergoing orthodontic treatment, using appliances, or using removable dentures,
- Individuals with acute dental infection or pain (cavities, abscesses, etc.).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Aantal groepen / cohorten
Cohorten en interventies
Groep / CohortGroep / Cohort |
|---|
|
Healthy Non-Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have never smoked or have not smoked for least 5 years.
|
|
Gingivitis Non-Smoker
Systemically healty individulas diagnosed with gingivitis who are non-smokers.
|
|
Periodontitis Non-Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who are non-smokers.
|
|
Healthy Smoker
Systemically healty individulas with clinically healthy periodontal tissues who have been smoking least 10 cigarettes per day for at least 1 year.
|
|
Gingivitis Smoker
Systemically healty individulas with gingivitis who have been smoking least 10 cigarettes per day for at least 1 year.
|
|
Periodontitis Smoker
Systemically healty individulas diagnosed with Stage III or IV periodontitis who who have been smoking least 10 cigarettes per day for at least 1 year.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Relative mRNA expression levels of TLR1,TLR4 and TLR6
Tijdsspanne: Baseline (At the clinical examination)
|
Metric:Fold change (2^-ΔΔCt method).
Measurement of gene expression levels in gingival tissues using the RT-PCR method.
|
Baseline (At the clinical examination)
|
|
Protein concerntrations of NLRP3, IL-18 and IL-1β
Tijdsspanne: Baseline (At the time of clinical examinat
|
Metric: Picograms per milliliter (pg/mL).
Evaluation of protein concentrations in gingival tissue samples using the ELISA method.
|
Baseline (At the time of clinical examinat
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Periodontal Inflamed Surface Area (PISA)
Tijdsspanne: Baseline (At the time of clinical examination)
|
Metric: square millimeters (mm²).
Calculation of the total periodontal inflamed surface area to quantify the inflammatory burden.
|
Baseline (At the time of clinical examination)
|
|
Periodontal Clinical Measurements (PD and CAL)
Tijdsspanne: Baseline (At the time of clinical examination)
|
Metric: millimeters (mm).
Measurements of Probing Depth (PD) and Clinical Attachment Level (CAL) using a periodontal probe.
|
Baseline (At the time of clinical examination)
|
|
Periodontal Indices (PI and GI)
Tijdsspanne: Baseline (At the time of clinical examination)
|
Metric: 0-3 numerical scale.
Assessment of Plaque Index (PI) and Gingival Index (GI) to evaluate oral hygiene and gingival inflammation.
|
Baseline (At the time of clinical examination)
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studie start
Primaire voltooiing (Werkelijk)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
Andere studie-ID-nummers
- 79-38
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .